|
Market Closed -
Nasdaq
06:00:00 03/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 135.07 USD | -0.01% |
|
-0.01% | +78.95% |
| 03/09 | AbbVie Closes $10.9 Billion Acquisition of Apogee Therapeutics | MT |
| 03/09 | Apogee Therapeutics, Inc.(NasdaqGM:APGE) dropped from S&P Biotechnology Select Industry Index | CI |
| Market Cap | 10.19B 8.76B 8.24B 7.52B 14.03B 966B 14.11B 97.63B 37.77B 494B 38.25B 37.42B 1,571B | P/E 2026 * |
-27.8x | P/E 2027 * | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 9.22B 7.93B 7.46B 6.81B 12.71B 875B 12.77B 88.41B 34.21B 447B 34.64B 33.88B 1,422B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 1,135x |
| Free-Float |
95.44% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| APGE | Delayed | |
CBOE
| APGE | Real-time |
Last Transcript : APOE THERPAR
| 1 day | -0.01% | ||
| 1 week | -0.01% | ||
| Current month | -0.01% | ||
| 1 month | +0.17% | ||
| 3 months | +62.72% | ||
| 6 months | +84.90% | ||
| Current year | +78.95% |
| 1 month | 134.4 |  | 135.09 |
| Current year | 60.35 | | 135.09 |
| 1 year | 35.39 | | 135.09 |
| 3 years | 14.19 | | 135.09 |
| 5 years | 14.19 | | 135.09 |
| 10 years | 14.19 | | 135.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jane Henderson
DFI | Director of Finance/CFO | 60 | 01/01/2023 |
Tim Piringer
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/2023 |
Carl Dambkowski
CTO | Chief Tech/Sci/R&D Officer | 41 | 01/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/9/26 | Fairmount Funds Management LLC
| Issuer sale | Company | -340,855 | 0.6087% | |
| 3/9/26 | Issuer sale | Director | -48,780 | 0.0871% | ||
| 3/9/26 | Venrock Associates
| Issuer sale | Company | -2,115,853 | 3.7784% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.01% | -0.01% | +251.56% | +482.45% | 10.19B | |
| -1.51% | -6.24% | -3.76% | +12.27% | 48.01B | |
| -1.29% | -1.22% | +404.92% | +545.45% | 44.44B | |
| -3.20% | +0.33% | +38.11% | +21.39% | 42.67B | |
| -1.89% | -2.00% | +1.45% | +82.46% | 39.96B | |
| -1.72% | -2.61% | +13.09% | +42.33% | 32.75B | |
| -0.17% | +3.78% | - | - | 17.74B | |
| -0.07% | +1.32% | +20.08% | +117.95% | 16.49B | |
| +0.59% | -1.59% | +11.98% | +32.19% | 14.38B | |
| -2.68% | -0.56% | +73.31% | +40.56% | 13.4B | |
| Average | -1.19% | -0.43% | +90.08% | +153.01% | 28B | |
| Weighted average by Cap. | -1.54% | -1.01% | +91.40% | +145.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 8.33M 7.16M 6.74M 6.15M 11.48M 790M 11.54M 79.87M 30.9M 404M 31.29M 30.61M 1.28B |
| Net income | -355M -305M -287M -262M -489M -33.67B -492M -3.4B -1.32B -17.21B -1.33B -1.3B -54.77B | -372M -320M -301M -275M -513M -35.27B -515M -3.57B -1.38B -18.03B -1.4B -1.37B -57.38B |
| Net Debt | -962M -827M -778M -710M -1.32B -91.15B -1.33B -9.22B -3.57B -46.59B -3.61B -3.53B -148B | -731M -629M -591M -540M -1.01B -69.32B -1.01B -7.01B -2.71B -35.43B -2.75B -2.69B -113B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/09/26 | USD 135.07 | -0.01% | 5,142,068 |
| 01/09/26 | USD 135.08 | 0.00% | 1,090,742 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- APGE Stock
Select your edition
All financial news and data tailored to specific country editions
